The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs)
Open accessAbstract
Antimicrobial peptides (AMPs) or host defense peptides protect the host against various pathogens such as yeast, fungi, viruses and bacteria. AMPs also display immunomodulatory properties ranging from the modulation of inflammatory responses to the promotion of wound healing. More interestingly, AMPs cause cell disruption through non-specific interactions with the membrane surface of pathogens. This is most likely responsible for the low or limited emergence of bacterial resistance against many AMPs. Despite the increasing number of antibiotic-resistant bacteria and the potency of novel AMPs to combat such pathogens, only a few AMPs are in clinical use. Therefore, the current review describes (i) the potential of AMPs as alternatives to antibiotics, (ii) the challenges toward clinical implementation of AMPs and (iii) strategies to improve the success rate of AMPs in clinical trials, emphasizing the lessons we could learn from these trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Bacteriocins: safe, natural antimicrobials for food preservation.
Cleveland, J., Montville, T. J., Nes, I. F., & Chikindas, M. L. (2001) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(01)00560-8 · Cited by 1,835
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Tryptophan- and arginine-rich antimicrobial peptides: Structures and mechanisms of action
Chan, D. I., Prenner, E. J., & Vogel, H. J. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.04.006 · Cited by 1,039
Matsuzaki, K. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00197-2 · Cited by 1,010
Applications of the bacteriocin, nisin
Delves-Broughton, J., Blackburn, P., Evans, R. J., & Hugenholtz, J. (1996) · Antonie van Leeuwenhoek · doi:10.1007/bf00399424 · Cited by 972
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides
Morrison, D. C., & Jacobs, D. M. (1976) · Immunochemistry · doi:10.1016/0019-2791(76)90181-6 · Cited by 819
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs
Gordon, Y. J., Romanowski, E. G., & McDermott, A. M. (2005) · Current Eye Research · doi:10.1080/02713680590968637 · Cited by 697
Arbeit, R. D., Maki, D., Tally, F. P., Campanaro, E., Eisenstein, B. I., & Daptomycin 98-01 and 99-01 Investigators (2004) · Clinical Infectious Diseases · doi:10.1086/420818 · Cited by 689
Conformation-dependent Antibacterial Activity of the Naturally Occurring Human Peptide LL-37
Johansson, J., Gudmundsson, G. H., Rottenberg, M. E., Berndt, K. D., & Agerberth, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3718 · Cited by 661
SON, D., LEE, J., LEE, Y., SONG, H., LEE, C., & HONG, J. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.04.004 · Cited by 633
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
Intracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 598
Development and Challenges of Antimicrobial Peptides for Therapeutic Applications
Chen, C. H., & Lu, T. K. (2020) · Antibiotics · doi:10.3390/antibiotics9010024 · Cited by 598
Gentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria
Li, J., Nation, R. L., Milne, R. W., Turnidge, J. D., & Coulthard, K. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.10.001 · Cited by 571
Nisin treatment for inactivation of Salmonella species and other gram-negative bacteria
Stevens, K. A., Sheldon, B. W., Klapes, N. A., & Klaenhammer, T. R. (1991) · Applied and Environmental Microbiology · doi:10.1128/aem.57.12.3613-3615.1991 · Cited by 570
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Alternative mechanisms of action of cationic antimicrobial peptides on bacteria
Hale, J. D., & Hancock, R. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.6.951 · Cited by 549
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 532
Jiang, Z., Vasil, A. I., Hale, J. D., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2008) · Peptide Science · doi:10.1002/bip.20911 · Cited by 505
The structure of melittin. II. Interpretation of the structure.
Terwilliger, T. C., & Eisenberg, D. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)65098-0 · Cited by 503
Antimicrobial Peptides: Successes, Challenges and Unanswered Questions
Wimley, W. C., & Hristova, K. (2011) · The Journal of Membrane Biology · doi:10.1007/s00232-011-9343-0 · Cited by 495
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Cao, X., Wang, Y., Wu, C., Li, X., Fu, Z., Yang, M., Bian, W., Wang, S., Song, Y., Tang, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-33558-w · Cited by 459
Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria
Batoni, G., Maisetta, G., & Esin, S. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.013 · Cited by 401
Nagy, I., Pivarcsi, A., Kis, K., Koreck, A., Bodai, L., McDowell, A., Seltmann, H., Patrick, S., Zouboulis, C. C., & Kemény, L. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.04.001 · Cited by 375
Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides
Rosenfeld, Y., Papo, N., & Shai, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504327200 · Cited by 370
Evolutionary Divergence of Substrate Specificity within the Chymotrypsin-like Serine Protease Fold
Perona, J. J., & Craik, C. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.29987 · Cited by 361
Dvorchik, B. H., Brazier, D., DeBruin, M. F., & Arbeit, R. D. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1318-1323.2003 · Cited by 358
Gottler, L. M., & Ramamoorthy, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.009 · Cited by 354
In vitro and In vivo Wound Healing-Promoting Activities of Human Cathelicidin LL-37
Carretero, M., Escámez, M. J., García, M., Duarte, B., Holguín, A., Retamosa, L., Jorcano, J. L., Río, M. D., & Larcher, F. (2008) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701043 · Cited by 345
Lipsky, B. A., Holroyd, K. J., & Zasloff, M. (2008) · Clinical Infectious Diseases · doi:10.1086/593185 · Cited by 324
Sakamoto, I., Igarashi, M., Kimura, K., Takagi, A., Miwa, T., & Koga, Y. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/47.5.709 · Cited by 304
Host defense antimicrobial peptides as antibiotics: design and application strategies
Mishra, B., Reiling, S., Zarena, D., & Wang, G. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.03.014 · Cited by 299
The action mechanism of daptomycin
Taylor, S. D., & Palmer, M. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.05.052 · Cited by 298
The antimicrobial peptide‐sensing system aps of Staphylococcus aureus
Li, M., Cha, D. J., Lai, Y., Villaruz, A. E., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05986.x · Cited by 297
Lee, G., & Bae, H. (2016) · Molecules · doi:10.3390/molecules21050616 · Cited by 275
Mohamed, M. F., Abdelkhalek, A., & Seleem, M. N. (2016) · Scientific Reports · doi:10.1038/srep29707 · Cited by 275
Antibacterial Mechanisms of Polymyxin and Bacterial Resistance
Yu, Z., Qin, W., Lin, J., Fang, S., & Qiu, J. (2015) · BioMed Research International · doi:10.1155/2015/679109 · Cited by 263
Nibbering, P. H., Ravensbergen, E., Welling, M. M., van Berkel, L. A., van Berkel, P. H. C., Pauwels, E. K. J., & Nuijens, J. H. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1469-1476.2001 · Cited by 261
Yu, K., Lo, J. C. Y., Yan, M., Yang, X., Brooks, D. E., Hancock, R. E. W., Lange, D., & Kizhakkedathu, J. N. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.047 · Cited by 256
Delivery systems for antimicrobial peptides
Nordström, R., & Malmsten, M. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.01.005 · Cited by 246
Dissemination of the mcr-1 colistin resistance gene
Arcilla, M. S., van Hattem, J. M., Matamoros, S., Melles, D. C., Penders, J., de Jong, M. D., & Schultsz, C. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00541-1 · Cited by 240
The Antimicrobial Peptide LL-37 Inhibits HIV-1 Replication
Bergman, P., Walter-Jallow, L., Broliden, K., Agerberth, B., & Soderlund, J. (2007) · Current HIV Research · doi:10.2174/157016207781023947 · Cited by 237
Dissemination of the mcr-1 colistin resistance gene
Olaitan, A. O., Chabou, S., Okdah, L., Morand, S., & Rolain, J.-M. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00540-x · Cited by 228
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
Ebenhan, T., Gheysens, O., Kruger, H. G., Zeevaart, J. R., & Sathekge, M. M. (2014) · BioMed Research International · doi:10.1155/2014/867381 · Cited by 225
Potential of immunomodulatory host defense peptides as novel anti-infectives
Easton, D. M., Nijnik, A., Mayer, M. L., & Hancock, R. E. W. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.004 · Cited by 215
On the Mechanism of Pore Formation by Melittin
van den Bogaart, G., Guzmán, J. V., Mika, J. T., & Poolman, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805171200 · Cited by 213
Valencia, R., Arroyo, L. A., Conde, M., Aldana, J. M., Torres, M.-J., Fernández-Cuenca, F., Garnacho-Montero, J., Cisneros, J. M., Ortiz, C., Pachón, J., et al. (2009) · Infection Control & Hospital Epidemiology · doi:10.1086/595977 · Cited by 211
Strömstedt, A. A., Pasupuleti, M., Schmidtchen, A., & Malmsten, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00477-08 · Cited by 200
Polymyxin B: similarities to and differences from colistin (polymyxin E)
Kwa, A., Kasiakou, S. K., Tam, V. H., & Falagas, M. E. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.5.811 · Cited by 190
Cathelicidin impact on inflammatory cells
Agier, J., Efenberger, M., & Brzezińska-Błaszczyk, E. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.51359 · Cited by 188
Comparative Mechanistic Studies of Brilacidin, Daptomycin, and the Antimicrobial Peptide LL16
Mensa, B., Howell, G. L., Scott, R., & DeGrado, W. F. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02955-14 · Cited by 185
Antibacterial efficacy of nisin against multidrug-resistant Gram- positive pathogens
Severina, E., Severin, A., & Tomasz, A. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.3.341 · Cited by 182
Resistance to bacteriocins produced by Gram-positive bacteria
Bastos, M. D. C. D. F., Coelho, M. L. V., & Santos, O. C. D. S. (2015) · Microbiology · doi:10.1099/mic.0.082289-0 · Cited by 181
Schneider, T., Gries, K., Josten, M., Wiedemann, I., Pelzer, S., Labischinski, H., & Sahl, H.-G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01040-08 · Cited by 181
Lacey, K. A., Geoghegan, J. A., & McLoughlin, R. M. (2016) · Pathogens · doi:10.3390/pathogens5010022 · Cited by 176
Recombinant production of antimicrobial peptides in heterologous microbial systems
Ingham, A. B., & Moore, R. J. (2007) · Biotechnology and Applied Biochemistry · doi:10.1042/ba20060207 · Cited by 175
Nell, M. J., Tjabringa, G. S., Wafelman, A. R., Verrijk, R., Hiemstra, P. S., Drijfhout, J. W., & Grote, J. J. (2006) · Peptides · doi:10.1016/j.peptides.2005.09.016 · Cited by 174
Ryu, S., Song, P. I., Seo, C., Cheong, H., & Park, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058753 · Cited by 173
Precision-guided antimicrobial peptide as a targeted modulator of human microbial ecology
Guo, L., McLean, J. S., Yang, Y., Eckert, R., Kaplan, C. W., Kyme, P., Sheikh, O., Varnum, B., Lux, R., Shi, W., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1506207112 · Cited by 172
Effect of hydrophobic modifications in antimicrobial peptides
Schmidtchen, A., Pasupuleti, M., & Malmsten, M. (2014) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.06.009 · Cited by 170
A Synthetic Antimicrobial Peptidomimetic (LTX 109): Stereochemical Impact on Membrane Disruption
Isaksson, J., Brandsdal, B. O., Engqvist, M., Flaten, G. E., Svendsen, J. S. M., & Stensen, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200450h · Cited by 169
Prince, A., Sandhu, P., Ror, P., Dash, E., Sharma, S., Arakha, M., Jha, S., Akhter, Y., & Saleem, M. (2016) · Scientific Reports · doi:10.1038/srep37908 · Cited by 165
Falanga, A., Lombardi, L., Franci, G., Vitiello, M., Iovene, M., Morelli, G., Galdiero, M., & Galdiero, S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050785 · Cited by 164
Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses
Brown, K. L., Poon, G. F. T., Birkenhead, D., Pena, O. M., Falsafi, R., Dahlgren, C., Karlsson, A., Bylund, J., Hancock, R. E. W., & Johnson, P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002508 · Cited by 163
TGF-α Regulates TLR Expression and Function on Epidermal Keratinocytes
Miller, L. S., Sørensen, O. E., Liu, P. T., Jalian, H. R., Eshtiaghpour, D., Behmanesh, B. E., Chung, W., Starner, T. D., Kim, J., Sieling, P. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6137 · Cited by 163
Shin, J. M., Ateia, I. M., Paulus, J. R., Liu, H., Fenno, J. C., Rickard, A. H., & Kapila, Y. L. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00617 · Cited by 162
Nardo, A. D., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., McInturff, J. E., Krutzik, S. R., Modlin, R. L., & Gallo, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1829 · Cited by 159
Susceptibility of Pseudomonas aeruginosa Biofilm to Alpha-Helical Peptides: D-enantiomer of LL-37
Dean, S. N., Bishop, B. M., & van Hoek, M. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00128 · Cited by 159
Falagas, M. E., Kasiakou, S. K., Tsiodras, S., & Michalopoulos, A. (2006) · Clinical Medicine & Research · doi:10.3121/cmr.4.2.138 · Cited by 158
Integration of nisin into nanoparticles for application in foods
Khan, I., & Oh, D. (2015) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2015.12.013 · Cited by 156
Murepavadin: a new antibiotic class in the pipeline
Martín‐Loeches, I., Dale, G. E., & Torres, A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1441024 · Cited by 156
Mechanisms of biofilm inhibition and degradation by antimicrobial peptides
Segev-Zarko, L.-A. T., Dover, R. S., Brumfeld, V., Mangoni, M. L., & Shai, Y. (2015) · Biochemical Journal · doi:10.1042/bj20141251 · Cited by 153
Sorensen, O. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28422 · Cited by 152
Gualillo, O., Lago, F., Gómez-Reino, J. J., Casanueva, F. F., & Diéguez, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00965-7 · Cited by 151
Probiotics in the critically ill: A systematic review of the randomized trial evidence
Petrof, E. O., Dhaliwal, R., Manzanares, W., Johnstone, J., Cook, D., & Heyland, D. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318260cc33 · Cited by 150
Bacalum, M., & Radu, M. (2014) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-014-9430-z · Cited by 150
Choi, J. H., Jang, A.-Y., Lin, S., Lim, S., KIM, D., Park, K., Han, S., Yeo, J., & Seo, H. S. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4275 · Cited by 148
Rand, K. H., & Houck, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2871-2875.2004 · Cited by 148
Melittin: a venom-derived peptide with promising anti-viral properties
Memariani, H., Memariani, M., Moravvej, H., & Shahidi‐Dadras, M. (2019) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-019-03674-0 · Cited by 143
Rene Dubos: unearthing antibiotics
Epps, H. L. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.2032fta · Cited by 137
Salmon, J. K., Armstrong, C. A., & Ansel, J. C. (1994) · PubMed Central · Cited by 136
The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
Boto, A., Pérez de la Lastra, J., & González, C. (2018) · Molecules · doi:10.3390/molecules23020311 · Cited by 136
The bactericidal/permeability-increasing protein (BPI) in infection and inflammatory disease
Schultz, H., & Weiss, J. P. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.07.005 · Cited by 125
Yasir, M., Dutta, D., & Willcox, M. D. P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215703 · Cited by 125
Jiang, Z., Vasil, A. I., Hale, J. D. F., Hancock, R. E. W., Vasil, M. L., & Hodges, R. S. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73657-0_246 · Cited by 122
Rdp58 Is a Novel and Potentially Effective Oral Therapy for Ulcerative Colitis
Travis, S. P. L., Yap, L. M., Hawkey, C., Warren, B. F., Lazarov, M. E., Fong, T., & Tesi, R. J. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000172807.26748.16 · Cited by 121
Doi, K., Hu, X., Yuen, P. S. T., Leelahavanichkul, A., Yasuda, H., Kim, S. M., Schnermann, J. B., Jonassen, T. E. N., Frøkiær, J., Nielsen, S., et al. (2008) · Kidney International · doi:10.1038/ki.2008.97 · Cited by 121
Crowther, G. S., Baines, S. D., Todhunter, S. L., Freeman, J., Chilton, C. H., & Wilcox, M. H. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks359 · Cited by 120
Rubinchik, E., Dugourd, D., de Algara, T. R., Pasetka, C., & Friedland, H. D. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.05.003 · Cited by 120
Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination
Lay, C., Dridi, L., Bergeron, M. G., Ouellette, M., & Fliss, I. (2015) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000202 · Cited by 117
Kaplan, C. W., Sim, J.-H., Shah, K. R., Kolesnikova-Kaplan, A., Shi, W., & Eckert, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-11 · Cited by 115
Boosting Salt Resistance of Short Antimicrobial Peptides
Chu, H., Yu, H., Yip, B., Chih, Y., Liang, C.-W., Cheng, H.-T., & Cheng, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00252-13 · Cited by 114
Functions of Antimicrobial Peptides in Host Defense and Immunity
Beißwenger, C., & Bals, R. (2005) · Current Protein and Peptide Science · doi:10.2174/1389203054065428 · Cited by 112
Fry, D. E. (2018) · Surgical Infections · doi:10.1089/sur.2018.194 · Cited by 111
Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture
Uğurlu, T., Türkoğlu, M., Gürer, Ü. S., & Akarsu, B. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.01.016 · Cited by 110
Salivary Histatin 5 and Human Neutrophil Defensin 1 Kill Candida albicans via Shared Pathways
Edgerton, M., Koshlukova, S. E., Araujo, M. W. B., Patel, R. C., Dong, J., & Bruenn, J. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3310-3316.2000 · Cited by 109
Synergistic combinations of polymyxins
Lenhard, J. R., Nation, R. L., & Tsuji, B. T. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.09.014 · Cited by 108
Blay, G. L., Lacroix, C., Zihler, A., & Fliss, I. (2007) · Letters in Applied Microbiology · doi:10.1111/j.1472-765x.2007.02178.x · Cited by 107
Piper, C., Hill, C., Cotter, P. D., & Ross, R. P. (2010) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2010.00207.x · Cited by 105
Induced conformational states of amphipathic peptides in aqueous/lipid environments
Blondelle, S. E., Ostresh, J. M., Houghten, R. A., & Pérez‐Payá, E. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)80194-3 · Cited by 105
Cornish, J., Callon, K. E., Lin, C. Q.-X., Xiao, C. L., Mulvey, T. B., Cooper, G. J. S., & Reid, I. R. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e779 · Cited by 101
Steenbergen, J. N., Mohr, J., & Thorne, G. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp346 · Cited by 94
In-VitroActivity of Nisin Against Clinical Isolates ofClostridium difficile
Bartoloni, A., Mantella, A., Goldstein, B. P., Dei, R., Benedetti, M. A., Sbaragli, S., & Paradisi, F. (2004) · Journal of Chemotherapy · doi:10.1179/joc.2004.16.2.119 · Cited by 93
Park, S., Kim, J., Shin, S.-O., Jeong, C.-Y., Kim, M., Shin, S. Y., Cheong, G., Park, Y., & Hahm, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.090 · Cited by 92
XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity
Ooi, N., Miller, K., Hobbs, J. K., Rhys‐Williams, W., Love, W. C., & Chopra, I. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp299 · Cited by 92
Synthetic Antimicrobial Peptides as Agricultural Pesticides for Plant‐Disease Control
Montesinos, E., & Bardají, E. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890111 · Cited by 91
on behalf of the Magic Bullet Working Group WP1, Cisneros, J. M., Rosso-Fernández, C. M., Roca-Oporto, C., PASCALE, G. D., Jiménez‐Jorge, S., Fernández-Hinojosa, E., Matthaiou, D. K., Ramírez, P., Díaz-Miguel, R. O., et al. (2019) · Critical Care · doi:10.1186/s13054-019-2627-y · Cited by 91
A Novel Drug for Treatment of Necrotizing Soft-Tissue Infections: A Randomized Clinical Trial
Bulger, E. M., Maier, R. V., Sperry, J. L., Joshi, M. G., Henry, S. M., Moore, F. A., Moldawer, L. L., Δημητριάδης, Δ., Talving, P., Schreiber, M. A., et al. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2013.4841 · Cited by 90
Host Cell Interactions Are a Significant Barrier to the Clinical Utility of Peptide Antibiotics
Starr, C. G., He, J., & Wimley, W. C. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00843 · Cited by 89
Mechanism of Action of Surface Immobilized Antimicrobial Peptides Against Pseudomonas aeruginosa
Yasir, M., Dutta, D., Hossain, K. R., Chen, R., Ho, K. K. K., Kuppusamy, R., Clarke, R. J., Kumar, N., & Willcox, M. D. P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03053 · Cited by 88
Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection
Oo, T. Z., Cole, N., Garthwaite, L. L., Willcox, M. D. P., & Zhu, H. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq106 · Cited by 86
Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide
Yu, H. B., Kielczewska, A., Rozek, A., Takenaka, S., Li, Y., Thorson, L., Hancock, R. E. W., Guarna, M. M., North, J. R., Foster, L. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.073627 · Cited by 84
Expression of antimicrobial peptides in diabetic foot ulcer
Rivas-Santiago, B. T., Trujillo, V., Montoya, A., Gonzalez-Curiel, I. E., Castañeda‐Delgado, J. E., Cardenas, A., Rincon, K., Hernandez, M. L., & Hernández‐Pando, R. (2011) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2011.09.013 · Cited by 84
Jang, W. S., Li, X. S., Sun, J. N., & Edgerton, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01199-07 · Cited by 83
Malanović, N., Leber, R., Schmuck, M., Kriechbaum, M., Cordfunke, R. A., Drijfhout, J. W., de Breij, A., Nibbering, P. H., Kolb, D., & Lohner, K. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.07.010 · Cited by 82
Thwaite, J. E., Hibbs, S., Titball, R. W., & Atkins, T. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01488-05 · Cited by 79
Points to consider on switching between superiority and non-inferiority.
(2001) · PubMed Central · doi:10.1046/j.0306-5251.2001.01397-3.x · Cited by 79
Gramicidin A: A New Mission for an Old Antibiotic
David, J. M., & Rajasekaran, A. K. (2015) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2015.21 · Cited by 77
Wecke, T., Zühlke, D., Mäder, U., Jordan, S., Voigt, B., Pelzer, S., Labischinski, H., Homuth, G., Hecker, M., & Mascher, T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01046-08 · Cited by 77
Ishida, H., Nguyen, L. T., Gopal, R., Aizawa, T., & Vogel, H. J. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06781 · Cited by 75
Eckert, R., Brady, K. M., Greenberg, E. P., Qi, F., Yarbrough, D. K., He, J. G., McHardy, I. H., Anderson, M. H., & Shi, W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00509-06 · Cited by 74
Kudrimoti, M. R., Amarintha, C., Azawi, S., Worden, F. P., Katz, S. R., Adkins, D., Bonomi, M. R., Elder, J., Sonis, S. T., Straube, R., et al. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.10.010 · Cited by 74
Rogers, J. M., & Suga, H. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01336d · Cited by 72
Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent
Fulco, P. P., & Wenzel, R. P. (2006) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.4.6.939 · Cited by 71
He, J. G., Yarbrough, D. K., Kreth, J., Anderson, M. H., Shi, W., & Eckert, R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01391-09 · Cited by 71
Origin and Diversity of Alginate Lyases of Families PL-5 and -7 in Sphingomonas sp. Strain A1
Miyake, O., Ochiai, A., Hashimoto, W., & Murata, K. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.9.2891-2896.2004 · Cited by 71
A Hydrogel‐Based Localized Release of Colistin for Antimicrobial Treatment of Burn Wound Infection
Zhu, C., Zhao, J., Kempe, K., Wilson, P., Wang, J., Velkov, T., Li, J., Davis, T. P., Whittaker, M. R., & Haddleton, D. M. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600320 · Cited by 71
Antimicrobial Peptide LL-37 and IDR-1 Ameliorate MRSA Pneumonia in Vivo
Hou, M., Zhang, N., Yang, H. J., Meng, X., Yang, R., Li, J., & Sun, T. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354465 · Cited by 67
Mercer, D. K., Robertson, J., Miller, L., Stewart, C. S., & O′Neil, D. A. (2020) · Medical Mycology · doi:10.1093/mmy/myaa015 · Cited by 67
Luo, X., Li, J., Huang, H., Duan, J., Dai, R., Tao, R., Yang, L., Hou, J., Jia, X., & Xu, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00283 · Cited by 66
Shurko, J. F., Galega, R., Li, C., & Lee, G. C. (2018) · The Journal of Antibiotics · doi:10.1038/s41429-018-0090-7 · Cited by 65
Targeted Antimicrobial Treatment to Re-establish a Healthy Microbial Flora for Long-term Protection
Eckert, R., Sullivan, R., & Shi, W. (2012) · Advances in Dental Research · doi:10.1177/0022034512453725 · Cited by 63
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones
Rodríguez, C. H., Ambrosio, A. D., Bajuk, M., Spinozzi, M., Nastro, M., Bombicino, K. A., Radice, M. A., Gutkind, G., Vay, C. A., & Famiglietti, A. M. R. (2010) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.604 · Cited by 63
Yang, C.-H., Chen, Y.-C., Peng, S.-Y., Tsai, A. P., Lee, T. J.-F., Yen, J.-H., & Liou, J.-W. (2018) · Scientific Reports · doi:10.1038/s41598-018-32981-3 · Cited by 61
Kramer, N. E., Hasper, H. E., van den Bogaard, P. T. C., et al. (2008) · Microbiology · doi:10.1099/mic.0.2007/015412-0 · Cited by 59
Antimicrobial Peptides and Their Analogs: Searching for New Potential Therapeutics
Midura‐Nowaczek, K., & Markowska, A. (2014) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s13215 · Cited by 58
Leeds, J. A., Sachdeva, M., Mullin, S., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06354-11 · Cited by 58
[Amino acid metabolism in larvae of the silkworm Bombyx mori].
Filippovich, I. B., & Bungova, V. G. (1968) · PubMed · Cited by 54
Jorgensen, J. H., Crawford, S. A., Kelly, C. C., & PATTERSON, J. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3760-3763.2003 · Cited by 52
Total Synthesis and Biological Mode of Action of WAP-8294A2: A Menaquinone-Targeting Antibiotic
Itoh, H., Tokumoto, K., Kaji, T., Paudel, A., Panthee, S., Hamamoto, H., Sekimizu, K., & Inoue, M. (2017) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.7b02318 · Cited by 50
Galar, A., Muñóz, P., Valerio, M., Cercenado, E., García‐González, X., Burillo, A., Sánchez-Somolinos, M., Juárez, M., Verde, E., & Bouza, E. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.09.015 · Cited by 49
Guinan, E. C., Barbon, C. M., Kalish, L. A., Parmar, K., Kutok, J. L., Mancuso, C. J., Stoler‐Barak, L., Suter, E. E., Russell, J. D., Palmer, C. D., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003126 · Cited by 46
Alam, Z. A., Wu, X., Mascio, C. T. M., Chesnel, L., & Hurdle, J. G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01087-15 · Cited by 45
Modulation of Neutrophil Apoptosis by Antimicrobial Peptides
Nagaoka, I., Suzuki, K., Niyonsaba, F., Tamura, H., & Hirata, M. (2012) · ISRN Microbiology · doi:10.5402/2012/345791 · Cited by 43
Phee, L. M., Betts, J. W., Bharathan, B., & Wareham, D. W. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00753-15 · Cited by 42
Cationic Antimicrobial Peptide Cytotoxicity
Laverty, G. (2014) · SOJ Microbiology & Infectious Diseases · doi:10.15226/sojmid.2013.00112 · Cited by 41
Sikora, K., Jaśkiewicz, M., Neubauer, D., Bauer, M., Bartoszewska, S., Barańska‐Rybak, W., & Kamysz, W. (2018) · Amino Acids · doi:10.1007/s00726-017-2536-9 · Cited by 37
Muchintala, D., Velpula, S., Raju, D., & Sashidhar, R. B. (2020) · Materials Science and Engineering C · doi:10.1016/j.msec.2020.110712 · Cited by 37
Al‐Kawas, F., Aslanian, H. R., Baillie, J. M., et al. (2018) · Trials · doi:10.1186/s13063-018-2473-2 · Cited by 33
McCrudden, M., McLean, D. T. F., Zhou, M., Shaw, J., Linden, G. J., Irwin, C. R., & Lundy, F. T. (2014) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-014-9410-3 · Cited by 30
Neu, T., & Henrich, B. (2003) · Applied and Environmental Microbiology · doi:10.1128/aem.69.3.1377-1382.2003 · Cited by 29
Edsfeldt, S., Holm, B., Mahlapuu, M., Reno, C. R., Hart, D. A., & Wiig, M. E. (2016) · Upsala Journal of Medical Sciences · doi:10.1080/03009734.2016.1230157 · Cited by 29
Brouwer, C. P. J. M. (2018) · Cohesive Journal of Microbiology & Infectious Disease · doi:10.31031/cjmi.2018.01.000512 · Cited by 23
Medhi, B., Sarma, P., Mahendiratta, S., & Prakash, A. (2018) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_218_18 · Cited by 21
Immunomodulatory and Kidney-Protective Effects of the Human Chorionic Gonadotropin Derivate EA-230
van Groenendael, R., Kox, M., van Eijk, L. T., & Pickkers, P. (2018) · The Nephron journals/Nephron journals · doi:10.1159/000490772 · Cited by 17
Csató, M., Kenderessy, A. S., & DOBOZY, A. (1989) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1989.tb01415.x · Cited by 16
Cheng, M. P., Lawandi, A., Butler‐Laporte, G., Paquette, K., & Lee, T. C. (2018) · Trials · doi:10.1186/s13063-018-2668-6 · Cited by 9
Natural biodegradable medical polymers
Fang, Z., Wusgal, Cheng, H., & Liang, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100372-5.00011-8 · Cited by 7
4.27 Polymeric Drug Conjugates by Controlled Radical Polymerization
Kim, S.-H., Nguyen, T. H. T., & Maynard, H. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-08-100691-7.00020-3 · Cited by 1
Cited by
The past, present, and future of antibiotics
Cook, M. A., & Wright, G. D. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abo7793 · Cited by 652
Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics
Murugaiyan, J., Kumar, P. A., Rao, G. S., Iskandar, K., Hawser, S., Hays, J. P., Mohsen, Y., Adukkadukkam, S., Awuah, W. A., Jose, R. A. M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11020200 · Cited by 567
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Antimicrobial Peptides: A Potent Alternative to Antibiotics
Rima, M., Rima, M., Fajloun, Z., Sabatier, J.-M., Bechinger, B., & Naas, T. (2021) · Antibiotics · doi:10.3390/antibiotics10091095 · Cited by 350
Antimicrobial Peptides—Mechanisms of Action, Antimicrobial Effects and Clinical Applications
Talapko, J., Meštrović, T., Juzbašić, M., Tomas, M., Erić, S., Horvat Aleksijević, L., Bekić, S., Schwarz, D., Matić, S., Neuberg, M., et al. (2022) · Antibiotics · doi:10.3390/antibiotics11101417 · Cited by 281
Metadata
- Authors
- Dijksteel, G. S., Ulrich, M. M. W., Middelkoop, E., & Boekema, B. K. H. L.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2021-02-22
- Volume
- 12
- Pages
- 616979-616979
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W3131431845
- Cited by
- 428
- References
- 174
- FWCI
- 36.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.